Abdominal aortic calcification quantified by the Morphological Atherosclerotic Calcification Distribution (MACD) index is associated with features of the metabolic syndrome

BMC Cardiovascular Disorders

Claus Christiansen³  Morten A Karsdal³  Lars M Rasmussen²  Thomas C Register⁴  Mads Nielsen¹  Melanie Ganz¹  Natasha Barascuk³ 

[1] Department of Computer Sciences, University of Copenhagen, Universitetsparken 1, 2100 Copenhagen Ø, Denmark;Department of Clinical Biochemistry, Odense University Hospital, University of Southern Denmark, 5000 Odense, Denmark;Nordic Bioscience A/S, Herlev Hovedgade 207, 2730 Herlev, Denmark;Department of Physiology, Section on Comparative Medicine, Wake Forest University Medical School, NC, USA

关键词: AAC24;    risk factors;    aortic calcification;    Cardiovascular disease;   

Others  :  1085465
DOI  :  10.1186/1471-2261-11-75

 received in 2011-08-10, accepted in 2011-12-20,  发布年份 2011

【 摘 要 】

Background

Abdominal aortic calcifications (AAC) predict cardiovascular mortality. A new scoring model for AAC, the Morphological Atherosclerotic Calcification Distribution (MACD) index may contribute with additional information to the commonly used Aortic Calcification Severity (AC24) score, when predicting death from cardiovascular disease (CVD). In this study we investigated associations of MACD and AC24 with traditional metabolic-syndrome associated risk factors at baseline and after 8.3 years follow-up, to identify biological parameters that may account for the differential performance of these indices.

Methods

Three hundred and eight healthy women aged 48 to 76 years, were followed for 8.3 ± 0.3 years. AAC was quantified using lumbar radiographs. Baseline data included age, weight, blood pressure, blood lipids, and glucose levels. Pearson correlation coefficients were used to test for relationships.

Results

At baseline and across all patients, MACD correlated with blood glucose (r² = 0.1, P< 0.001) and to a lesser, but significant extent with traditional risk factors (p < 0.01) of CVD. In the longitudinal analysis of correlations between baseline biological parameters and the follow-up calcification assessment using radiographs we found LDL-cholesterol, HDL/LDL, and the ApoB/ApoA ratio significantly associated with the MACD (P< 0.01). In a subset of patients presenting with calcification at both baseline and at follow-up, all cholesterol levels were significantly associated with the MACD (P< 0.01) index. AC24 index was not correlated with blood parameters.

Conclusion

Patterns of calcification identified by the MACD, but not the AC24 index, appear to contain useful biological information perhaps explaining part of the improved identification of risk of cardiovascular death of the MACD index. Correlations of MACD but not the AC24 with glucose levels at baseline suggest that hyperglycemia may contribute to unique patterns of calcification indicated by the MACD.

【 授权许可】

   
2011 Barascuk et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 2004, 173(2):381-391.
• [2]Mensah GA, Ryan US, Hooper WC, Engelgau MM, Callow AD, Kapuku GK, Mantovani A: Vascular endothelium summary statement II: Cardiovascular disease prevention and control. Vascul Pharmacol 2007, 46(5):318-320.
• [3]Kannel WB, Cupples A: Epidemiology and risk profile of cardiac failure. Cardiovasc Drugs Ther 1988, 2 Suppl 1:387-395.
• [4]Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298(3):309-316.
• [5]Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298(3):309-316.
• [6]Tanko LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C: Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005, 111(15):1883-1890.
• [7]Tanko LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C: Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005, 111(15):1883-1890.
• [8]Tanko LB, Bruun JM, Alexandersen P, Bagger YZ, Richelsen B, Christiansen C, Larsen PJ: Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 2004, 110(15):2246-2252.
• [9]Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C: Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003, 107(12):1626-1631.
• [10]Rifkin RD, Parisi AF, Folland E: Coronary calcification in the diagnosis of coronary artery disease. Am J Cardiol 1979, 44(1):141-147.
• [11]Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, Schwartz RS: Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998, 31(1):126-133.
• [12]Wilson PW, Kauppila LI, O'Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA: Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001, 103(11):1529-1534. %20
• [13]Iribarren C, Go AS, Tolstykh I, Sidney S, Johnston SC, Spring DB: Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt) 2004, 13(4):381-389.
• [14]Death AK, Fisher EJ, McGrath KC, Yue DK: High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003, 168(2):263-269.
• [15]Iribarren C, Go AS, Tolstykh I, Sidney S, Johnston SC, Spring DB: Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt) 2004, 13(4):381-389.
• [16]Eggen DA, Strong JP, McGill HC Jr: CALCIFICATION IN THE ABDOMINAL AORTA; RELATIONSHIP TO RACE, SEX, AND CORONARY ATHEROSCLEROSIS. Arch Pathol 1964, 78:575-583.
• [17]Eggen DA, Strong JP, McGill HC Jr: Coronary calcification. Relationship to clinically significant coronary lesions and race, sex, and topographic distribution. Circulation 1965, 32(6):948-955.
• [18]Nielsen M, Ganz M, Lauze F, Pettersen PC, de BM, Clarkson TB, Dam EB, Christiansen C, Karsdal MA: Distribution, size, shape, growth potential and extent of abdominal aortic calcified deposits predict mortality in postmenopausal women. BMC Cardiovasc Disord 2010, 10:56. BioMed Central Full Text
• [19]Ganz M, de BM, Dam EB, Karsdal MA, Christiansen C: Distribution, size, and shape of abdominal aortic calcified deposits and their relationship to mortality in post-menopausal women. 2011. Proceedings of the 97th Annual Meeting of the Radiological Society of North America (RSNA) 2011
• [20]Tanko LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C: Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005, 111(15):1883-1890.
• [21]Genant HK, Wu CY, van Kuijk C, Nevitt MC: Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8(9):1137-1148.
• [22]Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241(19):2035-2038.
• [23]Death AK, Fisher EJ, McGrath KC, Yue DK: High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003, 168(2):263-269.
• [24]Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241(19):2035-2038.
• [25]Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979, 59(1):8-13.
• [26]Farzaneh-Far A, Proudfoot D, Shanahan C, Weissberg PL: Vascular and valvar calcification: recent advances. Heart 2001, 85(1):13-17.
• [27]Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M: Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996, 16(8):978-983.
• [28]Giachelli CM: Vascular calcification mechanisms. J Am Soc Nephrol 2004, 15(12):2959-2964.
• [29]Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N: Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004, 43(3):572-579.
• [30]Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298(3):309-316.
• [31]Jacobson TA, Miller M, Schaefer EJ: Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther 2007, 29(5):763-777.
• [32]Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298(3):299-308.
• [33]Tanko LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C: Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005, 111(15):1883-1890. %19